Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea · Delayed Price · Currency is KRW 2,280.00
-25.00 (-1.08%)
At close: Jul 18, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY TTM | FY NaN | FY NaN | FY NaN | FY NaN | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
Antibiotics | 51.95B | Log In | Log In | Log In | Log In | Upgrade |
Antibiotics Growth | 12.52% | Log In | Log In | Log In | Log In | Upgrade |
Intravenous and Enteral Nutrition | 44.35B | Log In | Log In | Log In | Log In | Upgrade |
Intravenous and Enteral Nutrition Growth | 5.31% | Log In | Log In | Log In | Log In | Upgrade |
Circulatory System | 29.61B | Log In | Log In | Log In | Log In | Upgrade |
Circulatory System Growth | 4.52% | Log In | Log In | Log In | Log In | Upgrade |
Finished Products and Raw Materials | 27.59B | Log In | Log In | Log In | Log In | Upgrade |
Finished Products and Raw Materials Growth | 14.38% | Log In | Log In | Log In | Log In | Upgrade |
Neuropsychiatric System | 23.29B | Log In | Log In | Log In | Log In | Upgrade |
Neuropsychiatric System Growth | 11.54% | Log In | Log In | Log In | Log In | Upgrade |
Antipyretic, Analgesic and Anti-inflammatory | 16.46B | Log In | Log In | Log In | Log In | Upgrade |
Antipyretic, Analgesic and Anti-inflammatory Growth | -13.58% | Log In | Log In | Log In | Log In | Upgrade |
Respiratory System | 13.76B | Log In | Log In | Log In | Log In | Upgrade |
Respiratory System Growth | 8.26% | Log In | Log In | Log In | Log In | Upgrade |
Digestive System | 12.58B | Log In | Log In | Log In | Log In | Upgrade |
Digestive System Growth | 14.49% | Log In | Log In | Log In | Log In | Upgrade |
Processed Goods | 4.53B | Log In | Log In | Log In | Log In | Upgrade |
Processed Goods Growth | 18.63% | Log In | Log In | Log In | Log In | Upgrade |
Other | 27.94B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 4.48% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 27.94B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 4.48% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY TTM | FY NaN | FY NaN | FY NaN | FY NaN | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
Other | 2.34B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 126.11% | Log In | Log In | Log In | Log In | Upgrade |
South Korea | 224.46B | Log In | Log In | Log In | Log In | Upgrade |
South Korea Growth | 6.49% | Log In | Log In | Log In | Log In | Upgrade |
Japan | 23.95B | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | 23.53% | Log In | Log In | Log In | Log In | Upgrade |
Taiwan | 1.29B | Log In | Log In | Log In | Log In | Upgrade |
Taiwan Growth | -64.98% | Log In | Log In | Log In | Log In | Upgrade |
Other | 2.34B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 126.11% | Log In | Log In | Log In | Log In | Upgrade |
Sweden | - | Log In | Log In | Log In | Log In | Upgrade |